Pfizer chief executive Albert Bourla plans to meet Starboard Value, said people familiar with the matter, as the activist ...

CEO Albert Bourla is set to meet with activist investor Starboard Value amid growing pressure to revitalize the ...

Shares of Pfizer (NYSE: PFE) have been stuck in the mud since December 2022, with its shares down more than 45% over that ...

Starboard Value reportedly has taken a roughly $1 billion stake in Pfizer, as the activist investor seeks to turn the ...

Activist investor Starboard Value has taken a stake of about $1 billion in Pfizer Inc. and is seeking to spur a turnaround of ...

Two of Pfizer’s former top executives have pitched at least four of its directors, including chief executive Albert Bourla, on activist investor Starboard Value’s plan for turning around the ...

Pfizer’s CEO Ian Read is to step down after eight years and will be replaced on 1st January by chief operating officer Albert Bourla ... leadership – the breast cancer drug Ibrance has ...

Pfizer has promoted Albert Bourla, seen as a likely successor to incumbent CEO Ian Read, to the newly-created role of chief operating officer. The move could help Read focus on long-term strategy ...

US hedge fund Starboard now holds 0.6% of Pfizer’s value as the drugmaker struggles with its post-pandemic financial ...

Activist investor Starboard Value has taken a stake of about US$1bil in Pfizer Inc and is seeking to spur a turnaround of the ...

Pfizer has so far signed up less than a quarter of the countries targeted under a plan to make its medicines available to the ...

Companies with high dividend yields can seem attractive, but there is far more to income stocks than above-average yields.